Business
GeoVax Urges Immediate Action on Pandemic Preparedness as Biodefense Gaps Expose Fragile Supply Chains
With Mpox spreading globally, COVID-19 variants evading immunity, and bipartisan leaders demanding U.S.-based solutions, GeoVax calls for urgent investment in domestic manufacturing and vaccine diversification ATLANTA, GA - July 30, 2025 (NEWMEDIAWIR...
About this update from Geovax Labs, Inc.
[{"type":"image","caption":"","headline":"GeoVax Labs Announces $1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules","size":{"original":{"width":140,"height":140,"url":"https://media.zenfs.com/en/newsmediawire_165/6b870301b9c37c9b2d12fc8f9b2a2ecc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/CK3y_RQaAtNDQGf8lPQXOQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTIxMDtjZj13ZWJw/https://media.zenfs.com/en/newsmediawire_165/6b870301b9c37c9b2d12fc8f9b2a2ecc","width":140,"height":140}}},{"type":"text","content":"With Mpox spreading globally, COVID-19 variants evading immunity, and bipartisan leaders demanding U.S.-based solutions, GeoVax calls for urgent investment in domestic manufacturing and vaccine diversification","length":209,"tagName":"p"},{"type":"text","content":"ATLANTA, GA - July 30, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigenic vaccines and immunotherapies, today renewed its call for decisive U.S. action on pandemic preparedness and biodefense. With escalating outbreak risks, public health system strain, and growing bipartisan consensus for domestic solutions, GeoVax underscored the urgent need to modernize the nation's countermeasure infrastructure and end foreign vaccine dependency.","length":512,"tagName":"p"},{"type":"text","content":""The warning signs are multiplying," said David Dodd, Chairman and CEO of GeoVax. "We are facing the global expansion of virulent Mpox strains, immune-evasive COVID variants, and a national stockpile reliant on outdated, offshore platforms. Pandemic readiness must be built at home - with modern, American-made solutions and proactive government-industry leadership."","length":387,"tagName":"p"},{"type":"text","content":"GeoVax's Domestic Platform for Emerging and Endemic Threats","length":63,"tagName":"p"},{"type":"text","content":"GeoVax's Modified Vaccinia Ankara (MVA)-based vaccine platform anchors two front-line candidates:","length":101,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"GEO-MVA for Mpox/smallpox, designed to protect against both Clade I and II Mpox strains.","length":88,"tagName":"p"}]},{"val":[{"type":"text","content":"GEO-CM04S1, a multi-antigen, next-generation COVID-19 vaccine targeting the 40 million U.S. immunocompromised through robust, d...